Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

An In Vitro Partial Lesion Model of Differentiated Human Mesencephalic Neurons : Effect of Pericyte Secretome on Phenotypic Markers

Gaceb, Abderahim LU ; Barbariga, Marco LU and Paul, Gesine LU (2020) In Journal of Molecular Neuroscience 70(11). p.1914-1925
Abstract

Parkinson’s disease (PD) is characterised by the progressive degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta. Post-mortem data suggests that the loss of DA markers may long precede the cell death, leaving a window to rescue the DA phenotype. Screening for potential neuroprotective or restorative therapies, however, requires that partial lesions of DA neurons can be modelled in vitro. In order to establish a partial lesion model of DA neurons in vitro, we evaluated the effects of different exposure times to 1-methyl-4-phenylpyridinium (MPP+) and 6-hydroxydopamine (6-OHDA) on the cell survival and DA marker expression using DA neurons derived from the Lund human mesencephalic (LUHMES) cell line.... (More)

Parkinson’s disease (PD) is characterised by the progressive degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta. Post-mortem data suggests that the loss of DA markers may long precede the cell death, leaving a window to rescue the DA phenotype. Screening for potential neuroprotective or restorative therapies, however, requires that partial lesions of DA neurons can be modelled in vitro. In order to establish a partial lesion model of DA neurons in vitro, we evaluated the effects of different exposure times to 1-methyl-4-phenylpyridinium (MPP+) and 6-hydroxydopamine (6-OHDA) on the cell survival and DA marker expression using DA neurons derived from the Lund human mesencephalic (LUHMES) cell line. We show that 24-h incubation with 50 μM of MPP+ or 6-h incubation with 100 μM of 6-OHDA leads to a significant decrease in the protein expression of DA markers without affecting overall cell death, consistent with a mild DA lesion. Using conditioned medium of human brain–derived pericytes stimulated with platelet-derived growth factor BB (PDGF-BB), we demonstrate a significant upregulation of DA markers. In conclusion, we provide an experimental model of an in vitro DA neuron partial lesion suitable to study different molecules and their potential neuroprotective or neurorestorative effects on the DA phenotype. We provide evidence that the secretome of brain pericytes stimulated via PDGF-BB/PDGFRβ affects DA marker expression and may represent one possible mechanism contributing to the neurorestoration previously observed in PD by this growth factor.

(Less)
Please use this url to cite or link to this publication:
author
; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Brain pericytes, Dopaminergic neurons, Neurorestoration, Partial lesion, Platelet-derived growth factor BB, Secretome
in
Journal of Molecular Neuroscience
volume
70
issue
11
pages
12 pages
publisher
Humana Press
external identifiers
  • pmid:32472394
  • scopus:85085616002
ISSN
0895-8696
DOI
10.1007/s12031-020-01589-6
language
English
LU publication?
yes
id
3bbb178c-9a98-4e6b-a597-1387cc11c0c7
date added to LUP
2020-06-26 10:06:37
date last changed
2024-07-24 21:03:42
@article{3bbb178c-9a98-4e6b-a597-1387cc11c0c7,
  abstract     = {{<p>Parkinson’s disease (PD) is characterised by the progressive degeneration of dopaminergic (DA) neurons in the substantia nigra pars compacta. Post-mortem data suggests that the loss of DA markers may long precede the cell death, leaving a window to rescue the DA phenotype. Screening for potential neuroprotective or restorative therapies, however, requires that partial lesions of DA neurons can be modelled in vitro. In order to establish a partial lesion model of DA neurons in vitro, we evaluated the effects of different exposure times to 1-methyl-4-phenylpyridinium (MPP<sup>+</sup>) and 6-hydroxydopamine (6-OHDA) on the cell survival and DA marker expression using DA neurons derived from the Lund human mesencephalic (LUHMES) cell line. We show that 24-h incubation with 50 μM of MPP<sup>+</sup> or 6-h incubation with 100 μM of 6-OHDA leads to a significant decrease in the protein expression of DA markers without affecting overall cell death, consistent with a mild DA lesion. Using conditioned medium of human brain–derived pericytes stimulated with platelet-derived growth factor BB (PDGF-BB), we demonstrate a significant upregulation of DA markers. In conclusion, we provide an experimental model of an in vitro DA neuron partial lesion suitable to study different molecules and their potential neuroprotective or neurorestorative effects on the DA phenotype. We provide evidence that the secretome of brain pericytes stimulated via PDGF-BB/PDGFRβ affects DA marker expression and may represent one possible mechanism contributing to the neurorestoration previously observed in PD by this growth factor.</p>}},
  author       = {{Gaceb, Abderahim and Barbariga, Marco and Paul, Gesine}},
  issn         = {{0895-8696}},
  keywords     = {{Brain pericytes; Dopaminergic neurons; Neurorestoration; Partial lesion; Platelet-derived growth factor BB; Secretome}},
  language     = {{eng}},
  number       = {{11}},
  pages        = {{1914--1925}},
  publisher    = {{Humana Press}},
  series       = {{Journal of Molecular Neuroscience}},
  title        = {{An In Vitro Partial Lesion Model of Differentiated Human Mesencephalic Neurons : Effect of Pericyte Secretome on Phenotypic Markers}},
  url          = {{http://dx.doi.org/10.1007/s12031-020-01589-6}},
  doi          = {{10.1007/s12031-020-01589-6}},
  volume       = {{70}},
  year         = {{2020}},
}